Former taoiseach Enda Kenny has been appointed as a non-executive director of Tipperary-based Envetec Sustainable Technologies Ltd, a start-up company focused on treating and eradicating biohazardous laboratory waste and material.
Mr Kenny (71), who was taoiseach from 2011 to 2017, is one of five recent appointments to the board of the cleantech business, which has raised €10 million in new funding to support its growth. Mr Kenny has secured a number of directorships since stepping down as taoiseach, including with Heneghan, the Ireland China Institute and Carbon Collect Ltd.
The other board members are Michael Dowling, president and chief executive of Northwell Health; Eva Pisa, a former senior vice-president of Roche Diagnostics; Imogen Joss, former president of S&P Global Market Intelligence and Platts, and now chair of Grant Thornton UK; and James Connelly, chief executive of My Green Lab.
“We have identified five outstanding independent directors who have the right mix of leadership skills and experience underscored by a genuine, collective passion for advancing best-in-class technologies that benefit the environment and the economy,” said Malcolm Bell, chairman and chief executive of Envetec.
Rachel O’Dwyer: My son Ted is about to finish three years of leukaemia treatment. What happens now?
Joe Biden may be best to let sleeping dogs lie as new books lifts lid on his final days in office
An Irishman in Israel: Is it better for my Israeli daughters to grow up in Tel Aviv or Dublin?
‘We try to assist the seed of belief’: Pope’s deal with Communist party in China draws criticism from some Catholics
“With these new additions to the board, Envetec is strongly positioned across the diagnostic, pharmaceutical, medical device, and food and beverage industries with an opportunity to impact the environmental footprint of the customers we serve.”
According to the company, its generations technology safely treats biohazardous waste and materials including plastics, glass, PPE, sharps containers and other general laboratory consumables on-site. The patented technology shreds and disinfects infectious waste and materials directly at the source, which can then be recycled.
It is designed to help laboratories begin phasing out unsustainable activities, including incineration, autoclaving, landfill and the public health risk associated with the transportation of biohazardous waste.
